Uganda’s health authorities have disclosed that the woman who tested positive for Bundibugyo virus disease in Nigeria had no visible symptoms when she left Uganda.
The disclosure was contained in a statement released on October 23 by the country’s Director General of Health Services, Professor Charles Olaro, who said investigations were underway to determine when the woman began experiencing symptoms and how she contracted the virus.
According to the ministry, Ugandan officials are working with Nigerian health authorities to trace the woman’s movements, establish her travel history and identify possible sources of exposure.
The ministry has also requested detailed travel records and genomic sequencing information, where available, to help establish the circumstances surrounding the infection.
Following the development, Uganda has reintroduced locator forms for all travellers entering the country to improve monitoring and enable health officials to trace contacts when necessary.
The government has also strengthened infection prevention measures at border crossings and healthcare facilities while maintaining surveillance for possible cases.
As part of additional restrictions, travellers who have visited the Democratic Republic of Congo will not be allowed to transit through Uganda. The ministry warned that individuals who violate public health regulations or enter the country through unofficial routes could face action from the relevant authorities.
Residents have been urged to report unauthorised border crossings, maintain good hand hygiene and cooperate with screening procedures at entry points.
The ministry reassured the public that Uganda remained free of Ebola and appealed to citizens and travellers to remain calm while observing recommended health precautions.
It also recognised the contributions of government agencies, the Africa Centres for Disease Control and Prevention, the United States Centers for Disease Control and Prevention, and the World Health Organisation to the ongoing investigation.
Authorities in Uganda and Nigeria are continuing their joint efforts to establish the timeline of the infection and assess any potential public health risks.
